Model Smarter, Not Harder: Introducing Model Designer Webinar Model Smarter, Not Harder: Introducing Model Designer June 30, 2026, 10:00 – 11:00 AM ET | July 2, 2026, 10:00 – 11:00…Danielle PillsburyJune 10, 2026
Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study Poster Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study Download this poster to see how Certara used quantitative systems pharmacology (QSP) to translate ¹⁷⁷Lu-PSMA-617…CertaraJune 9, 2026
Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies Poster Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies Explore how population PK modeling predicts absorbed dose and biologically effective dose for radioligand therapies.CertaraJune 9, 2026
Beyond Compliance: What ICH M15 Means for the Future of Drug Development Blog Beyond Compliance: What ICH M15 Means for the Future of Drug Development Explore how ICH M15 is shaping regulatory expectations for Model-Informed Drug Development (MIDD), including model…CertaraJune 9, 2026
Applying AI-Driven Biosimulation to Drug Discovery Video Applying AI-Driven Biosimulation to Drug Discovery Certara President Leif Pedersen explains how PBPK and QSP modeling, proven across 125+ FDA-approved drugs,…CertaraJune 2, 2026
Certainty US 2026 recap: advancing model-informed drug development right from the start Blog Certainty US 2026 recap: advancing model-informed drug development right from the start This blog shares the highlights of our US Certainty event and explains how AI-enabled approaches…CertaraMay 26, 2026
Population Pharmacokinetic Modeling of Niraparib to Assess Different Absorption Models Publication Population Pharmacokinetic Modeling of Niraparib to Assess Different Absorption Models This publication describes the development of an updated population pharmacokinetic (PopPK) model for niraparib, a…CertaraMay 21, 2026
Pharmacometrics Under Pressure Part 3: The Wall: When the Model Gets Harder Than Planned On-Demand Webinar Pharmacometrics Under Pressure Part 3: The Wall: When the Model Gets Harder Than Planned Learn how Phoenix NLME and RsNLME support advanced PK/PD workflows and complex pharmacometric modeling through…CertaraMay 20, 2026
Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace On-Demand Webinar Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace See how Phoenix NLME and RsNLME support scalable and manageable workflows as project demands evolve.Danielle PillsburyMay 8, 2026
What We Learned at Phoenix UGM at Certainty 2026 About the Future of PK/PD Blog What We Learned at Phoenix UGM at Certainty 2026 About the Future of PK/PD JTVCdGVhbV9qdW1wX2xpc3QlNUQ= May 8, 2026 At Certainty 2026, the Phoenix User Group Meeting brought together scientists,…CertaraMay 8, 2026